MYNZ
Price
$1.49
Change
+$0.06 (+4.20%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
6.55M
23 days until earnings call
STXS
Price
$2.54
Change
+$0.04 (+1.60%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
225.63M
87 days until earnings call
Interact to see
Advertisement

MYNZ vs STXS

Header iconMYNZ vs STXS Comparison
Open Charts MYNZ vs STXSBanner chart's image
Mainz Biomed
Price$1.49
Change+$0.06 (+4.20%)
Volume$100
Capitalization6.55M
Stereotaxis
Price$2.54
Change+$0.04 (+1.60%)
Volume$805
Capitalization225.63M
MYNZ vs STXS Comparison Chart in %
Loading...
MYNZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MYNZ vs. STXS commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MYNZ is a StrongBuy and STXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (MYNZ: $1.43 vs. STXS: $2.50)
Brand notoriety: MYNZ and STXS are both not notable
MYNZ represents the Medical Specialties, while STXS is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: MYNZ: 31% vs. STXS: 234%
Market capitalization -- MYNZ: $6.55M vs. STXS: $225.63M
MYNZ [@Medical Specialties] is valued at $6.55M. STXS’s [@Pharmaceuticals: Other] market capitalization is $225.63M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $168.51B to $0. The average market capitalization across the [@Medical Specialties] industry is $9.89B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MYNZ’s FA Score shows that 1 FA rating(s) are green whileSTXS’s FA Score has 0 green FA rating(s).

  • MYNZ’s FA Score: 1 green, 4 red.
  • STXS’s FA Score: 0 green, 5 red.
According to our system of comparison, STXS is a better buy in the long-term than MYNZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MYNZ’s TA Score shows that 5 TA indicator(s) are bullish while STXS’s TA Score has 5 bullish TA indicator(s).

  • MYNZ’s TA Score: 5 bullish, 5 bearish.
  • STXS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, STXS is a better buy in the short-term than MYNZ.

Price Growth

MYNZ (@Medical Specialties) experienced а +7.52% price change this week, while STXS (@Pharmaceuticals: Other) price change was +12.61% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.92%. For the same industry, the average monthly price growth was +1.56%, and the average quarterly price growth was -1.80%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.28%. For the same industry, the average monthly price growth was -2.96%, and the average quarterly price growth was +3.30%.

Reported Earning Dates

MYNZ is expected to report earnings on Sep 03, 2025.

STXS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical Specialties (+3.92% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (+2.28% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STXS($226M) has a higher market cap than MYNZ($6.55M). STXS YTD gains are higher at: 9.649 vs. MYNZ (-66.898). STXS has more cash in the bank: 10.6M vs. MYNZ (978K). STXS has less debt than MYNZ: STXS (5.87M) vs MYNZ (8.27M).
MYNZSTXSMYNZ / STXS
Capitalization6.55M226M3%
EBITDAN/A-24.72M-
Gain YTD-66.8989.649-693%
P/E RatioN/AN/A-
RevenueN/A27.5M-
Total Cash978K10.6M9%
Total Debt8.27M5.87M141%
FUNDAMENTALS RATINGS
STXS: Fundamental Ratings
STXS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
60
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MYNZSTXS
RSI
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
75%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 22 days ago
77%
Bullish Trend 15 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 11 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
78%
Aroon
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
MYNZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DPXCF0.04N/A
N/A
DelphX Capital Markets Inc.
GLXZ2.90N/A
N/A
Galaxy Gaming, Inc.
OLCLF21.74N/A
N/A
Oriental Land Co., Ltd.
SHJBF1.97N/A
N/A
SHANGHAI JUNSHI BIOSCIENCES CO LTD.
PBTDF0.80N/A
N/A
PLOVER BAY TECHNOLOGIES LTD.

MYNZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, MYNZ has been loosely correlated with ACRS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MYNZ jumps, then ACRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYNZ
1D Price
Change %
MYNZ100%
-1.38%
ACRS - MYNZ
40%
Loosely correlated
+3.82%
STXS - MYNZ
25%
Poorly correlated
+14.16%
SINT - MYNZ
23%
Poorly correlated
+7.64%
BLFS - MYNZ
23%
Poorly correlated
N/A
CVRX - MYNZ
22%
Poorly correlated
+4.32%
More

STXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, STXS has been loosely correlated with SMTI. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then SMTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STXS
1D Price
Change %
STXS100%
+14.16%
SMTI - STXS
39%
Loosely correlated
+1.81%
TWST - STXS
37%
Loosely correlated
+2.56%
PSNL - STXS
33%
Loosely correlated
-0.77%
BLFS - STXS
33%
Poorly correlated
N/A
VCYT - STXS
33%
Poorly correlated
-1.12%
More